基于浊毒理论治疗代谢相关脂肪性肝病理论探析及应用体会
DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R575.5

基金项目:

河南省中医药科学研究专项课题(2018ZY2004)


Theory Analysis and Application Experience of Treating Metabolic Associated Fatty Liver Disease Based on Turbid Toxin Theory
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    随着肥胖及其代谢综合征全球化流行的趋势,代谢相关脂肪性肝病正严重威胁国人的健康,成为仅次于病毒性肝炎的第二大肝病。本文通过探究其病因病机,以国医大师李佃贵教授“浊毒理论”立论,临床上以化浊解毒、散瘀降脂辨证论治取得了良好疗效,为中医药治疗本病提供了新的思路和方法,使浊毒理论更好地服务于中医临床。

    Abstract:

    Abstract: With the global trend of obesity and its metabolic syndrome, metabolic associated fatty liver disease is a serious threat to the health of Chinese people,being the second threatening liver disease after viral hepatitis. Through the exploration of etiology and pathogenesis and on the basis of “turbid toxin theory” of professor LI Diangui,the master of Chinese medicine, this paper has found that the syndrome differentiation and treatment of resolving turbidity and detoxicating,and dissipating stasis and lowering lipid can achieve a good curative effect clinically,which provides a new idea and method for the treatment of the disease,and makes the turbid toxin theory better serve the clinical practice of Chinese medicine.

    参考文献
    相似文献
    引证文献
引用本文

解冬,党中勤,孙晓娜,刘洋,耿晓超.基于浊毒理论治疗代谢相关脂肪性肝病理论探析及应用体会[J].新中医,2021,53(16):201-203

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2021-08-23
  • 出版日期: